Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.31) by 177.42 percent. This is a 258.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.23 million which beat the analyst consensus estimate of $950.00 thousand by 28.95 percent. This is a 8.45 percent decrease over sales of $1.34 million the same period last year.
Armata Pharmaceuticals Q3 EPS $(0.86) Misses $(0.31) Estimate, Sales $1.23M Beat $950.00K Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.